Spain - Pharmaceuticals
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 14 October 2019
- Opportunity publication date
- 16 September 2019
- Category
- 33600000: Pharmaceutical products
- Value of contract
- £1m-5m
- Your guide to exporting
Description
Active substance: Acyclovir (DOE)Quantity of active substance: 250 mgPharmaceutical form: vial or ampoulePackaging conditions: unit doseMaximum unit price: EUR 2,00/vial or ampouleNumber of units planned: 37 000 vials or ampoulesEstimated maximum budget: EUR 74 000,00 (first year of contract) Active substance: Rocuronium (DOE)Quantity of active substance: 50 mgPharmaceutical form: vialPackaging conditions: unit doseMaximum unit price: 6,48 EUR/5 vials (excluding taxes)Number of units planned: 92 000 vialsEstimated maximum budget: 119 232,00 EUR (first year of contract) Active substance: Human coagulation factor IX (DOE) Quantity of active ingredient: 1 200 UIForma farmacéutica: vialPackaging conditions: unit doseMaximum unit price: 480,29 EUR/vial (taxes not included)Number of units planned: 600 vialsEstimated maximum budget: 288 174,00 EUR (first year of contract) Active ingredient: Immunoglobulin from rabbit antitimocytes (DOE)Quantity of active substance: 25 mgPharmaceutical form: vialPackaging conditions: unit doseMaximum unit price: 126,84 EUR/vial (taxes not included)Number of units planned: 1 500 vialsEstimated maximum budget: 190 260,00 EUR (first year of contract)
- Opportunity closing date
- 14 October 2019
- Value of contract
- £1m-5m
About the buyer
- Address
- Dirección General — Osakidetza — Servicio Vasco de Salud C/ Álava, 45 Vitoria-Gasteiz 01006 Spain
- Contact
- contrata@osakidetza.eus
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.